21 NHS hospital trusts recorded no net improvement in their elective care waiting lists across the first eleven months of 2025-26, then reversed their backlogs entirely in March. For those trusts, a single month did the work of a year. Health leaders are now asking what that actually means for the state of the waiting list recovery.
The data covering the preceding eleven months shows patient treatment timelines at these trusts either plateauing or worsening before the sudden correction. In several cases, waiting lists grew during the autumn and winter period before dropping sharply as the financial year closed. The result is a statistical picture in which one month outweighs the combined output of the other eleven, which is not how a functioning recovery normally looks.
Two broad factors appear to explain the March surge. The first is operational: centrally coordinated initiatives and short-term funding released ahead of the financial year-end drove additional activity, including weekend lists, extended evening sessions and the deployment of independent sector capacity. These measures were effective at shifting numbers quickly. The second factor is administrative. Back-office data validation exercises, which include removing duplicate entries, updating records for patients who have moved or died, and auditing lists for errors, can produce significant apparent improvements in waiting time figures without any increase in the number of patients actually treated. Both types of activity took place across the health service in March, and separating their contribution to the headline numbers is not straightforward.
The sustainability concern is direct. Concentrating a year's worth of progress into four weeks requires staff overtime, emergency procurement and management attention that cannot simply be repeated in April and May. The clinical and administrative workforce involved in those surges does not reset at the start of a new financial year. Several trust medical directors have warned privately that the conditions that produced the March figures are not replicable on a rolling basis, and that expecting similar performance in the first quarter of 2026-27 is unrealistic given the pace at which new referrals continue to arrive.
That last point matters more than the year-end figures suggest. Even where trusts succeeded in reducing their lists in March, the underlying rate at which patients are being referred into elective pathways continues to outpace routine treatment capacity at many sites. A sprint that clears a backlog in one month does not expand the permanent infrastructure needed to handle the following month's demand at the same rate. Without that capacity, lists begin to rebuild almost immediately after the pressure eases.
The picture is not uniform across the health service. A number of trusts made steady, incremental reductions throughout the year by redesigning patient pathways, shifting work between sites and recruiting to fill longstanding clinical vacancies. Their year-end figures are less dramatic precisely because they did not need a late correction. These organisations tend to have lower variance between monthly performance data and are better placed to absorb volume fluctuations without resorting to emergency measures. They are also, notably, a minority. A significant proportion of trusts saw their waiting lists deteriorate over the full twelve months, with no recovery in March sufficient to offset earlier losses.
The political pressure to meet year-end waiting list targets is not incidental to any of this. Trusts operate within a performance framework that places weight on where numbers land at the end of March, which creates an incentive to prioritise that window over the eleven months preceding it. Whether that incentive produces better outcomes for patients over time, or simply produces better-looking data at a fixed point in the calendar, is the question that the current evidence makes harder to avoid.
If the structural gap between referral volumes and baseline capacity is not addressed, the most likely outcome in the coming quarters is a return to the position trusts were in before March. The year-end figures will have served their purpose in the annual accounts. The waiting lists, in many cases, will not have.
